AnnMarieNavarMDPhD, FACC, FAHA, FASCP

PubMed

• 22 citations
  An Approach to Improve the Negative Predictive Value and Clinical Utility of Transthoracic Echocardiography in Suspected Native Valve Infective Endocarditis.
  Joseph A. Sivak, Amit N. Vora, Ann Marie Navar, Phillip J. Schulte, Anna Lisa Crowley
  Journal of the American Society of Echocardiography. 2016-04-01
• 77 citations
  Managing Atherosclerotic Cardiovascular Risk in Young Adults: JACC State-of-the-Art Review.
  Neil J Stone, Sidney C Smith Jr, Carl E Orringer, Nancy A Rigotti, Ann Marie Navar
  Journal of the American College of Cardiology. 2022-03-01
• 15 citations
  Shared Decisions: A Qualitative Study on Clinician and Patient Perspectives on Statin Therapy and Statin-Associated Side Effects.
  Sarah T. Ahmed, Julia M. Akeroyd, Dhruv Mahtta, Richard L. Street, Jason Slagle
  Journal of the American Heart Association. 2020-11-17

Journal Articles

• Choosing an Initial Therapeutic Approach for Hypertension—Time for a Fixed-Dose Combination First?  
  Ann Marie Navar, Thomas J Wang, JAMA Cardiology
• Heroism in the Face of the COVID-19 Pandemic  
  Ajay J Kirtane, Ann Marie Navar, JAMA Cardiology
• Moving Beyond Regression Techniques in Cardiovascular Risk Prediction: Applying Machine Learning to Address Analytic Challenges  
  Ann Navar, MD, European Heart Journal

Abstracts/Posters

• [Board 414] Triglycerides as a Risk Factor For Coronary Heart Disease: What Measure and What Cutoff?
  Ann Navar, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/18/2019

Lectures

• Deep Dive II 
  2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019